Author name: admingav

Delegates attending Saturday afternoon’s Speakers’ Corner session on imaging heard colleagues describe interesting cases and findings from prospective and retrospective clinical studies evaluating the performance of different imaging platforms for characterising known and recently described retinal features associated with common and rare diseases.   Speakers’ Corner, a popular feature of the Euretina Congress programme, gives

A study detailing the pros and cons of using silicone oil as a long-term tamponade agent after complex retinal surgery was the winner of the inaugural August Deutman prize for the best e-Poster. “We know that silicone oil is a widely used tamponade agent in complex retinal surgery, but it should be used with caution

Delegates filling the Auditorium on Saturday morning for the RETINAWS video course were rewarded with a valuable learning experience as top surgeons from around the world presented and discussed video excerpts showcasing complex vitreoretinal surgery, rare situations, and unique surgical techniques. The session started, however, with course director Dr Kourous Rezaei (United States) showing a

The PULSAR trial in wet age-related macular degeneration demonstrated that aflibercept 8 mg administered every 12 or 16 weeks is noninferior in vision gains compared with aflibercept 2 mg every 8 weeks. The 60-week and 96-week outcomes of the trial were presented by Paolo Lanzetta MD, who was designated winner of the inaugural August Deutman

Everybody loves a good detective mystery and retinal specialists are no exception.  At the Medical Retina Mystery Cases session, the assembled audience was presented with a wide variety of puzzling case studies which highlighted the complex process of arriving at a correct diagnosis. Opening the session, Srinivas Sadda MD presented the intriguing case of a

If current trends continue, one out of every two people on the planet will be myopic by the year 2050. Even more worryingly, a significant proportion of these will be highly myopic with all the associated problems that entails in terms of ocular morbidity, disease and vision loss, according to a number of speakers at

Prof. Ramin Tadayoni, the incoming President of EURETINA, discusses the challenges and opportunities facing the Society over the next few years To what do you attribute the phenomenal growth of EURETINA in recent years? Ramin Tadayoni: EURETINA is still quite a young Society and a lot has been achieved in a short space of time.